Takeda in talks with Shire after $61 billion bid rejected

LONDON/NEW YORK (Reuters) - Japan's Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid worth around $61 billion that was rejected by the London-listed rare diseases drugmaker.